The next board meeting for Silence Therapeutics PLC (ADR) is on 19 May 2026 for the purpose of H.C. Wainwright BioConnect Investor ConferenceSee details
Silence Therapeutics PLC (ADR) has a share price target of US$ 31, revenue growth forecast of 64.3%, and profit growth estimate of 26.0% for FY26, based on top 6 analyst calls.